Stockscreener 앱 받기
4.27
1.84%
-0.08
시간 외 거래:
4.14
-0.13
-3.04%
전일 마감가:
$4.35
열려 있는:
$4.3
하루 거래량:
121.88K
Relative Volume:
0.67
시가총액:
$153.99M
수익:
-
순이익/손실:
-
주가수익비율:
-2.1583
EPS:
-1.9784
순현금흐름:
-
1주 성능:
-11.41%
1개월 성능:
-0.93%
6개월 성능:
-3.61%
1년 성능:
+0.00%
1일 변동 폭
$4.21
$4.4924
1주일 범위
$4.17
$5.15
52주 변동 폭
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
AVR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
4.27 | 156.87M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
538.82 | 192.92B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.04 | 50.82B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.19 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.40 | 36.34B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
286.94 | 20.13B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
What analysts say about Anteris Technologies Global Corp stockEarnings Date Calendar & Affordable Stock Market Tips - earlytimes.in
Anteris Technologies Global Corp. stock momentum explained2025 Institutional Moves & Accurate Trade Setup Notifications - newser.com
Anteris Technologies Global (AVR) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Should you wait for a breakout in Anteris Technologies Global Corp.July 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Will Anteris Technologies Global Corp. continue its uptrendJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
Using flow based indicators on Anteris Technologies Global Corp.July 2025 Short Interest & Long-Term Growth Plans - newser.com
Anteris Technologies Updates Capital Raising Timetable - MSN
Anteris Technologies Announces Cessation of Securities - The Globe and Mail
How strong is Anteris Technologies Global Corp. stock balance sheetLayoff News & Free Long-Term Investment Growth Plans - newser.com
Detecting price anomalies in Anteris Technologies Global Corp. with AIJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Using data models to predict Anteris Technologies Global Corp. stock movement2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Is Anteris Technologies Global Corp. stock oversold or undervaluedJuly 2025 Volume & Daily Entry Point Alerts - newser.com
Can Anteris Technologies Global Corp. hit a new high this monthPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
What does recent volatility data suggest for Anteris Technologies Global Corp.Long Setup & Entry Point Confirmation Signals - newser.com
Anteris Technologies: Strategic Advancements and FDA Approval Bolster Buy Rating - TipRanks
Anteris Technologies Secures FDA Approval for Global PARADIGM Trial - MSN
Will Anteris Technologies Global Corp. see short term momentum - newser.com
Anteris Technologies Receives FDA Approval for PARADIGM Trial - TipRanks
Anteris Technologies Global Corp FDA Approval for PARADIGM Trial - TradingView
[8-K] Anteris Technologies Global Corp. Reports Material Event | AVR SEC FilingForm 8-K - Stock Titan
What machine learning models say about Anteris Technologies Global Corp.2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the 'PARADIGM Trial”) - The Manila Times
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”) - Stock Titan
Anteris Technologies Initiates Global Trial for Innovative Heart Valve - MSN
Analyzing Anteris Technologies Global Corp. with multi timeframe chartsJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Is it time to cut losses on Anteris Technologies Global Corp.2025 Year in Review & Expert Verified Movement Alerts - newser.com
Published on: 2025-11-03 02:48:19 - newser.com
Why Anteris Technologies Global Corp. stock is seen as undervalued - newser.com
How rising interest rates impact Anteris Technologies Global Corp. stockWeekly Loss Report & Low Drawdown Investment Ideas - newser.com
Anteris Technologies Receives US FDA Approval for Transcatheter Heart Valve Trial; Shares Up 11% - MarketScreener
Will Anteris Technologies Global Corp. stock continue dividend increasesRecession Risk & Verified Chart Pattern Trade Signals - newser.com
Anteris Technologies Global Corp says FDA approves DurAVR THV global pivotal trial - MarketScreener
Is Anteris Technologies Global Corp. stock a safe buy before earningsGDP Growth & Weekly Market Pulse Updates - newser.com
Anteris Technologies Global Corp. (AVR.AX) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Anteris Technologies Global Corp. (AVR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Combining machine learning predictions for Anteris Technologies Global Corp.Earnings Recap Report & Fast Gaining Stock Reports - newser.com
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anteris Technologies Global Corp 주식 (AVR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
| Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
1.48%
0.69%
자본화:
|
볼륨(24시간):